Gene · 411
Papers1,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Artificially Sweetened Beverages Beyond the Metabolic Risks: A Systematic Review of the Literature. | Cureus | 2023 | 36741610 | PubTator, text mining | PubMed |
| Gene therapy for lysosomal storage diseases: Current clinical trial prospects. | Front Genet | 2023 | 36713078 | PubTator, text mining | PubMed |
| Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders. | Adv Drug Deliv Rev | 2023 | 36657645 | PubTator, text mining | PubMed |
| Structural and functional mapping of ars gene cluster in Deinococcus indicus DR1. | Comput Struct Biotechnol J | 2023 | 36618989 | PubTator, text mining | PubMed |
| Differential CpG DNA methylation of peripheral B cells, CD4+ T cells, and salivary gland tissues in IgG4-related disease. | Arthritis Res Ther | 2023 | 36609529 | PubTator, text mining | PubMed |
| Soil pH determines arsenic-related functional gene and bacterial diversity in natural forests on the Taibai Mountain. | Environ Res | 2023 | 36586710 | PubTator, text mining | PubMed |
| Reducing the inhibitive effect of fluorine and heavy metals on nitrate reduction by hydroxyapatite substrate in constructed wetlands. | J Hazard Mater | 2023 | 36586330 | PubTator, text mining | PubMed |
| Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC. | SN Comput Sci | 2023 | 36573207 | PubTator, text mining | PubMed |
| Rapid Targeted Sequencing Using Dried Blood Spot Samples for Patients With Suspected Actionable Genetic Diseases. | Ann Lab Med | 2023 | 36544340 | PubTator, text mining | PubMed |
| Antimony oxidation and whole genome sequencing of Phytobacter sp. X4 isolated from contaminated soil near a flotation site. | J Hazard Mater | 2023 | 36444812 | PubTator, text mining | PubMed |
| NF-κB represses retinoic acid receptor-mediated GPRC5A transactivation in lung epithelial cells to promote neoplasia. | JCI Insight | 2023 | 36413416 | PubTator, text mining | PubMed |
| Emerging systemic treatment options in meningioma. | J Neurooncol | 2023 | 36181606 | PubTator, text mining | PubMed |
| Loss of mitochondrial fatty acid β-oxidation protein short-chain Enoyl-CoA hydratase disrupts oxidative phosphorylation protein complex stability and function. | FEBS J | 2023 | 35962613 | PubTator, text mining | PubMed |
| The articular and the craniocervical abnormalities are of confusing age of onset in patients with Maroteaux-Lamy disease (MPS VI). | Minerva Pediatr (Torino) | 2023 | 32748606 | PubTator, text mining | PubMed |
| Liver-Directed Adeno-Associated Virus-Mediated Gene Therapy for Mucopolysaccharidosis Type VI. | NEJM Evid | 2022 | 38319253 | PubTator, text mining | PubMed |
| Computational and Experimental Evaluation of Linker Peptides and Thioredoxin Fusion Tag in CD20-rituximab Specific Interactions. | Iran J Pharm Res | 2022 | 36942068 | PubTator, text mining | PubMed |
| In silico analyses of diversity and dissemination of antimicrobial resistance genes and mobile genetics elements, for plasmids of enteric pathogens. | Front Microbiol | 2022 | 36777021 | PubTator, text mining | PubMed |
| Effect of static magnetic field on marine mollusc Elysia leucolegnote. | Front Mol Biosci | 2022 | 36703918 | PubTator, text mining | PubMed |
| Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets. | Int J Mol Sci | 2022 | 36613919 | PubTator, text mining | PubMed |
| Delayed Onset Post-Operative Neurologic Deficit in a Patient With Mucopolysaccharidosis type VI: A Case Report. | Iowa Orthop J | 2022 | 36601232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/411/papers?page=10